TS inhibition is central to the anti-tumor activity of FPs [10], and colorectal (CRC) tumors that respond to 5-FU were found to express low levels of TS and two other enzymes that affect 5-FU metabolism: DPD and thymidine phosphorylase (TP) [48]. Here, TYMP is linked to colorectal carcinoma.